These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 22805221)

  • 1. Association of MYH9/APOL1 with chronic kidney disease in a UK population.
    McKnight AJ; Duffy S; Fogarty DG; Maxwell AP
    Nephrol Dial Transplant; 2012 Sep; 27(9):3660; author reply 660-1. PubMed ID: 22805221
    [No Abstract]   [Full Text] [Related]  

  • 2. Polymorphisms in MYH9 are associated with diabetic nephropathy in European Americans.
    Cooke JN; Bostrom MA; Hicks PJ; Ng MC; Hellwege JN; Comeau ME; Divers J; Langefeld CD; Freedman BI; Bowden DW
    Nephrol Dial Transplant; 2012 Apr; 27(4):1505-11. PubMed ID: 21968013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effects of MYH9 and APOL1 risk variants on FRMD3 Association with Diabetic ESRD in African Americans.
    Freedman BI; Langefeld CD; Lu L; Divers J; Comeau ME; Kopp JB; Winkler CA; Nelson GW; Johnson RC; Palmer ND; Hicks PJ; Bostrom MA; Cooke JN; McDonough CW; Bowden DW
    PLoS Genet; 2011 Jun; 7(6):e1002150. PubMed ID: 21698141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between
    Zhao H; Ma L; Yan M; Wang Y; Zhao T; Zhang H; Liu P; Liu Y; Li P
    J Diabetes Res; 2018; 2018():5068578. PubMed ID: 29862302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-muscle myosin heavy chain 9 gene MYH9 associations in African Americans with clinically diagnosed type 2 diabetes mellitus-associated ESRD.
    Freedman BI; Hicks PJ; Bostrom MA; Comeau ME; Divers J; Bleyer AJ; Kopp JB; Winkler CA; Nelson GW; Langefeld CD; Bowden DW
    Nephrol Dial Transplant; 2009 Nov; 24(11):3366-71. PubMed ID: 19567477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The MYH9/APOL1 region and chronic kidney disease in European-Americans.
    O'Seaghdha CM; Parekh RS; Hwang SJ; Li M; Köttgen A; Coresh J; Yang Q; Fox CS; Kao WH
    Hum Mol Genet; 2011 Jun; 20(12):2450-6. PubMed ID: 21429915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Missense mutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to the MYH9 gene.
    Tzur S; Rosset S; Shemer R; Yudkovsky G; Selig S; Tarekegn A; Bekele E; Bradman N; Wasser WG; Behar DM; Skorecki K
    Hum Genet; 2010 Sep; 128(3):345-50. PubMed ID: 20635188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sickle cell trait is not independently associated with susceptibility to end-stage renal disease in African Americans.
    Hicks PJ; Langefeld CD; Lu L; Bleyer AJ; Divers J; Nachman PH; Derebail VK; Bowden DW; Freedman BI
    Kidney Int; 2011 Dec; 80(12):1339-43. PubMed ID: 21849968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kidney disease and African ancestry.
    Pollak MR
    Nat Genet; 2008 Oct; 40(10):1145-6. PubMed ID: 18818713
    [No Abstract]   [Full Text] [Related]  

  • 10. Polymorphisms in the non-muscle myosin heavy chain 9 gene (MYH9) are strongly associated with end-stage renal disease historically attributed to hypertension in African Americans.
    Freedman BI; Hicks PJ; Bostrom MA; Cunningham ME; Liu Y; Divers J; Kopp JB; Winkler CA; Nelson GW; Langefeld CD; Bowden DW
    Kidney Int; 2009 Apr; 75(7):736-45. PubMed ID: 19177153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Re-Sequencing of the APOL1-APOL4 and MYH9 Gene Regions in African Americans Does Not Identify Additional Risks for CKD Progression.
    Hawkins GA; Friedman DJ; Lu L; McWilliams DR; Chou JW; Sajuthi S; Divers J; Parekh RS; Li M; Genovese G; Pollack MR; Hicks PJ; Bowden DW; Ma L; Freedman BI; Langefeld CD
    Am J Nephrol; 2015; 42(2):99-106. PubMed ID: 26343748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of candidate nephropathy susceptibility genes in a genome-wide association study of African American diabetic kidney disease.
    Palmer ND; Ng MC; Hicks PJ; Mudgal P; Langefeld CD; Freedman BI; Bowden DW
    PLoS One; 2014; 9(2):e88273. PubMed ID: 24551085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymorphisms in the non-muscle myosin heavy chain gene (MYH9) are associated with lower glomerular filtration rate in mixed ancestry diabetic subjects from South Africa.
    Matsha TE; Masconi K; Yako YY; Hassan MS; Macharia M; Erasmus RT; Kengne AP
    PLoS One; 2012; 7(12):e52529. PubMed ID: 23285077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MYH9 and APOL1 are both associated with sickle cell disease nephropathy.
    Ashley-Koch AE; Okocha EC; Garrett ME; Soldano K; De Castro LM; Jonassaint JC; Orringer EP; Eckman JR; Telen MJ
    Br J Haematol; 2011 Nov; 155(3):386-94. PubMed ID: 21910715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MYH9 is associated with nondiabetic end-stage renal disease in African Americans.
    Kao WH; Klag MJ; Meoni LA; Reich D; Berthier-Schaad Y; Li M; Coresh J; Patterson N; Tandon A; Powe NR; Fink NE; Sadler JH; Weir MR; Abboud HE; Adler SG; Divers J; Iyengar SK; Freedman BI; Kimmel PL; Knowler WC; Kohn OF; Kramp K; Leehey DJ; Nicholas SB; Pahl MV; Schelling JR; Sedor JR; Thornley-Brown D; Winkler CA; Smith MW; Parekh RS;
    Nat Genet; 2008 Oct; 40(10):1185-92. PubMed ID: 18794854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dense mapping of MYH9 localizes the strongest kidney disease associations to the region of introns 13 to 15.
    Nelson GW; Freedman BI; Bowden DW; Langefeld CD; An P; Hicks PJ; Bostrom MA; Johnson RC; Kopp JB; Winkler CA
    Hum Mol Genet; 2010 May; 19(9):1805-15. PubMed ID: 20124285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. African ancestry allelic variation at the MYH9 gene contributes to increased susceptibility to non-diabetic end-stage kidney disease in Hispanic Americans.
    Behar DM; Rosset S; Tzur S; Selig S; Yudkovsky G; Bercovici S; Kopp JB; Winkler CA; Nelson GW; Wasser WG; Skorecki K
    Hum Mol Genet; 2010 May; 19(9):1816-27. PubMed ID: 20144966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MYH9 genetic variants associated with glomerular disease: what is the role for genetic testing?
    Kopp JB; Winkler CA; Nelson GW
    Semin Nephrol; 2010 Jul; 30(4):409-17. PubMed ID: 20807613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between a MYH9 polymorphism (rs3752462) and renal function in the Spanish RENASTUR cohort.
    Tavira B; Coto E; Gómez J; Tranche S; Miguélez K; Ortega F; Díez B; Sánchez E; Marín R; Arenas J; Alvarez V
    Gene; 2013 May; 520(1):73-6. PubMed ID: 23470845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MYH9 and APOL1 gene polymorphisms and the risk of CKD in patients with lupus nephritis from an admixture population.
    Colares VS; Titan SM; Pereira Ada C; Malafronte P; Cardena MM; Santos S; Santos PC; Fridman C; Barros RT; Woronik V
    PLoS One; 2014; 9(3):e87716. PubMed ID: 24658608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.